Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).

MLA

Samuel, Michelle, et al. “Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).” European Heart Journal. Quality of Care & Clinical Outcomes, vol. 7, no. 5, Sept. 2021, pp. 486–95. EBSCOhost, https://doi.org/10.1093/ehjqcco/qcaa045.

APA

Samuel, M., Tardif, J.-C., Khairy, P., Roubille, F., Waters, D. D., Grégoire, J. C., Pinto, F. J., Maggioni, A. P., Diaz, R., Berry, C., Koenig, W., Ostadal, P., Lopez-Sendon, J., Gamra, H., Kiwan, G. S., Dubé, M.-P., Provencher, M., Orfanos, A., Blondeau, L., … Lelorier, J. (2021). Cost-effectiveness of low-dose colchicine after myocardial infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT). European Heart Journal. Quality of Care & Clinical Outcomes, 7(5), 486–495. https://doi.org/10.1093/ehjqcco/qcaa045

Chicago

Samuel, Michelle, Jean-Claude Tardif, Paul Khairy, François Roubille, David D Waters, Jean C Grégoire, Fausto J Pinto, et al. 2021. “Cost-Effectiveness of Low-Dose Colchicine after Myocardial Infarction in the Colchicine Cardiovascular Outcomes Trial (COLCOT).” European Heart Journal. Quality of Care & Clinical Outcomes 7 (5): 486–95. doi:10.1093/ehjqcco/qcaa045.